학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 220건 | 목록 1~10
Academic Journal
Roussot N; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; INSERM U1231, 21000 Dijon, France.; Constantin G; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France.; Desmoulins I; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Bergeron A; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.; Arnould L; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.; Beltjens F; Department of Biology and Pathology of tumors, Georges Francois Leclerc Cancer Centre, Dijon, France.; Mayeur D; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Kaderbhai C; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Hennequin A; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Jankowski C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Padeano MM; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Costaz H; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Jacinto S; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Michel E; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Amet A; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Coutant C; Department of Surgical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; University of Burgundy-Franche Comté, 21000 Dijon, France.; Costa B; Department of Medical Oncology, Institut Jean Godinot, Reims, France.; Jouannaud C; Department of Medical Oncology, Institut Jean Godinot, Reims, France.; Deblock M; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France.; Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France.; Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.; Kerbrat P; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.; Brain E; Department of Medical Oncology, Institut Curie, Centre René Huguenin, Saint-Cloud, France.; Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.; Coudert B; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France.; Bertaut A; Unit of Methodology and Biostatistics, Georges Francois Leclerc Cancer Centre, Dijon, France.; Ladoire S; Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; University of Burgundy-Franche Comté, 21000 Dijon, France; INSERM U1231, 21000 Dijon, France. Electronic address: sladoire@cgfl.fr.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
von der Maase H; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Hansen SW; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Roberts JT; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Dogliotti L; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Oliver T; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Moore MJ; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Bodrogi I; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Albers P; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Knuth A; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Lippert CM; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Kerbrat P; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Sanchez Rovira P; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Wersall P; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Cleall SP; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Roychowdhury DF; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Tomlin I; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Visseren-Grul CM; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.; Conte PF; From the Aarhus University Hospital, Aarhus; Herlev Hospital, University of Copenhagen, Herlev, Denmark; Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle; St Bartholomews Hospital, London, United Kingdom; University of Torino, St Luigi Hospital, Orbassano; Santa Chiara Hospital, Pisa, Italy; The Princess Margaret Hospital, Toronto, Canada; National Institute of Oncology, Budapest, Hungary; Department of Urology, Bonn University, Bonn; Krankenhaus Nordwest, Frankfurt; Klinikum Ludwigshafen, Ludwigshafen, Germany; Centre Eugene Marquis, Rennes, France; Hospital Ciudad De Jaen, Jaen, Spain; Karolinska Hospital, Stockholm, Sweden; and Eli Lilly and Company, Indianapolis, IN.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Marec-Berard P; Unité de Traitement de la Douleur de l'Enfant, Centre Léon Bérard, Institut d'Hématologie et d'Oncologie Pédiatrie, Lyon, France.; Laurence V; Department of Medical Oncology, Institut Curie, Paris, France.; Occean BV; Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France.; Ray-Coquard I; Centre Léon Bérard, University Claude Bernard, Lyon, France.; Linassier C; Department of Cancer Medicine, Centre Hospitalo-Universitaire, Tours, France.; Corradini N; Department of Pediatric and Adolescent Hematology-Oncology, Hôpital Mère-Enfant, Nantes, France.; Collard O; Department of Medical Oncology, Institut de Cancérologie de la Loire, Lucien Neuwirth, St Priest en Jarez, France.; Chaigneau L; Department of Medical Oncology, CHRU Jean Minjoz, Besançon, France.; Cupissol D; Department of Medical Oncology, Centre Val d'Aurelle, Montpellier, France.; Kerbrat P; Department of Medical Oncology, Centre Eugène-Marquis, Rennes, France.; Saada-Bouzid E; Medical Oncology Department, Centre Antoine Lacassagne, Nice, France.; Delcambre C; Medical Oncology Department, Centre Francois Baclesse, Caen, France.; Gouin F; CHU Nantes Hôtel-Dieu/Laboratoire UMR1238 Phyos, Faculté de Médecine de Nantes, Nantes, France.; Guillemet C; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.; Jimenez M; R&D Unicancer, Paris, France.; Lervat C; Pediatric Oncology Unit-Adolescents and Young Adults, Centre Oscar Lambret, Lille, France.; Gaspar N; Department of Pediatric Oncology, Institut Gustave Roussy, Villejuif, France.; Le Deley MC; Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France.; Brugieres L; Department of Pediatric Oncology, Institut Gustave Roussy, Villejuif, France.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.
Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2156-535X (Electronic) Linking ISSN: 21565333 NLM ISO Abbreviation: J Adolesc Young Adult Oncol Subsets: MEDLINE
Academic Journal
Basse C; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Penel N; Department of Medical Oncology, Centre Oscar Lambret, CHRU, Lille, France.; Mir O; Department of Orthopedic and Traumatology Surgery, University Hospital, Lille, France.; Chemin C; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.; Duffaud F; Department of Medical Oncology, Timone University Hospital, Marseille, France.; Le Cesne A; Department of Medicine and Surgery, Gustave Roussy Cancer Campus, Paris, France.; Chevreau C; Medical Oncology, University Institute of Cancerology, Toulouse, France.; Maynou C; Department of Medical Oncology, Centre Oscar Lambret, CHRU, Lille, France.; Anract P; Orthopaedic Department, Cochin University Hospital, Paris, France.; Gouin F; Department of Orthopedic Surgery, Nantes University Hospital, Nantes, France.; Rios M; Department of Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy, France.; Firmin N; Department of Medicine, Val d'Aurelle Institute, Montpellier, France.; Kurtz JE; Medical Oncology & Orthopedy Department, Strasbourg University Hospital, Rennes, France.; Kerbrat P; Centre Eugène Marquis, Medical Oncology, Rennes, France.; Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France.; Bertucci F; Département of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Rosset P; Department of Orthopedic and Traumatology Surgery, Tours University Hospital, Tours, France.; Isambert N; Centre Georges-Francois Leclerc, Dijon, France.; Bompas E; Medical Oncology Department, René Gauducheau, Saint-Herblain, France.; Dubray-Longeras P; Centre Jean Perrin, Clermont-Ferrand, France.; Fiorenza F; Department of Orthopedics Surgery and Traumatology, Limoges University Hospital, Limoges, France.; Le Maignan C; Department of Dermatology and INSERM Unité 976, Saint Louis University Hospital, Paris, France.; Chaigneau L; Department of Medical Oncology, Jean Minjoz University Hospital, Besançon, France.; Thyss A; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.; Bouché O; Institut Jean Godinot & Reims University Hospital, Reims, France.; Eymard JC; Institut Jean Godinot & Reims University Hospital, Reims, France.; Delcambre Lair C; Department of Medicine, François-Baclesse Institute, Caen, France.; Adam J; Department of Medical Oncology, Timone University Hospital, Marseille, France.; Karanian M; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Lebbé C; Department of Dermatology and INSERM Unité 976, Saint Louis University Hospital, Paris, France.; Dupré A; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Meeus P; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Brahmi M; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Dufresne A; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Ducimetière F; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Ray-Coquard I; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.; Blay JY; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Kerbrat P
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어